Sensitivity of normal-based triple sampling sequential point estimation to the normality assumption

This article discusses the sensitivity of the sequential normal-based triple sampling procedure for estimating the population mean to departures from normality. We assume only that the underlying population has finite but unknown first four moments and find that asymptotically the behaviour of the estimator and the sample size depend on both the skewness and kurtosis of the underlying distribution, when using a squared error loss function with linear sampling cost. We supplement our findings with a simulation experiment to study the performance of the estimator and the sample size in a range of conditions

Some problems in the detection and accommodation of outliers in gamma samples

SIGLEAvailable from British Library Document Supply Centre- DSC:D69934/86 / BLDSC - British Library Document Supply CentreGBUnited Kingdo

Statistical analysis of reliability data

IndexBibl. : 233-243vii, 250 hlm. ;il. ;24 cm

Comparison of some robust estimators of scale in gamma samples with known shape

SIGLEAvailable from British Library Lending Division - LD:8723.403(22) / BLDSC - British Library Document Supply CentreGBUnited Kingdo

Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN study

<b>Background</b>: The lipid-modulatory effects of high intakes of the fish-oil fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are well established and likely to contribute to cardioprotective benefits. <b>Objectives</b>: We aimed to determine the effect of moderate EPA and DHA intakes (<2 g EPA+DHA/d) on the plasma fatty acid profile, lipid and apolipoprotein concentrations, lipoprotein subclass distribution, and markers of oxidative status. We also aimed to examine the effect of age, sex, and apolipoprotein E (APOE) genotype on the observed responses. <b>Design</b>: Three hundred twelve adults aged 20–70 y, who were prospectively recruited according to age, sex, and APOE genotype, completed a double-blind placebo-controlled crossover study. Participants consumed control oil, 0.7 g EPA+DHA/d (0.7FO), and 1.8 g EPA+DHA/d (1.8FO) capsules in random order, each for an 8-wk intervention period, separated by 12-wk washout periods. <b>Results</b>: In the group as a whole, 8% and 11% lower plasma triacylglycerol concentrations were evident after 0.7FO and 1.8FO, respectively (P < 0.001): significant sex x treatment (P = 0.038) and sex x genotype x treatment (P = 0.032) interactions were observed, and the greatest triacylglycerol-lowering responses (reductions of 15% and 23% after 0.7FO and 1.8FO, respectively) were evident in APOE4 men. Furthermore, lower VLDL-cholesterol (P = 0.026) and higher LDL-cholesterol (P = 0.010), HDL-cholesterol (P < 0.001), and HDL2 (P < 0.001) concentrations were evident after fish-oil intervention. <b>Conclusions</b>: Supplements providing EPA+DHA at doses as low as 0.7 g/d have a significant effect on the plasma lipid profile. The results of the current trial, which used a prospective recruitment approach to examine the responses in population subgroups, are indicative of a greater triacylglycerol-lowering action of long-chain n–3 polyunsaturated fatty acids in males than in females